Cargando…
Repurposing Selective Serotonin Reuptake Inhibitors for COVID-19: Rationale and Concerns
Autores principales: | Navin, Karthick, Kuppili, Pooja Patnaik, Menon, Vikas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735235/ https://www.ncbi.nlm.nih.gov/pubmed/33354088 http://dx.doi.org/10.1177/0253717620963338 |
Ejemplares similares
-
Heart Rate Recovery and Selective Serotonin Reuptake
Inhibitors
por: Cerit, Levent
Publicado: (2016) -
Biological rhythm impairment in bipolar disorder: A state or trait marker?
por: Kuppili, Pooja Patnaik, et al.
Publicado: (2018) -
Suicide Prevention Strategies for General Hospital and Psychiatric Inpatients: A Narrative Review
por: Navin, Karthick, et al.
Publicado: (2019) -
Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: author's response
por: Deng, Jiawen, et al.
Publicado: (2023) -
Improvement of Post Stroke Echolalia after Using Selective Serotonin Reuptake Inhibitors
por: Bae, Heewon, et al.
Publicado: (2019)